The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients

Thumbnail
Fulltext:
246489.pdf
Size:
836.8Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Dhooge, P.P.A.
Moller, P.
Boon, C.J.F.
Lotery, A.J.
Herrmann, P.
Battaglia Parodi, M.
Klein, Wolfgang
Fsadni, M.G.
Wheeler-Schilling, T.H.
Jungman, O.
Muller, Hans
Holz, F.G.
Schmitz-Valckenberg, S.
Peters, T.M.
Stingl, Katarina
Hoyng, C.B.
Source
Open Research Europe, 1, (2021), article 96
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/246489   https://hdl.handle.net/2066/246489
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.